| Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease R Pfeifle, T Rothe, N Ipseiz, HU Scherer, S Culemann, U Harre, ... Nature immunology 18 (1), 104-113, 2017 | 366 | 2017 |
| 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance S Uderhardt, M Herrmann, OV Oskolkova, S Aschermann, W Bicker, ... Immunity 36 (5), 834-846, 2012 | 283 | 2012 |
| Microbiota from obese mice regulate hematopoietic stem cell differentiation by altering the bone niche Y Luo, GL Chen, N Hannemann, N Ipseiz, G Krönke, T Bäuerle, L Munos, ... Cell metabolism 22 (5), 886-894, 2015 | 195 | 2015 |
| IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation M Faas, N Ipseiz, J Ackermann, S Culemann, A Grüneboom, F Schröder, ... Immunity 54 (11), 2531-2546. e5, 2021 | 126 | 2021 |
| PPARβ/δ governs Wnt signaling and bone turnover C Scholtysek, J Katzenbeisser, H Fu, S Uderhardt, N Ipseiz, C Stoll, ... Nature medicine 19 (5), 608-613, 2013 | 126 | 2013 |
| 12/15-lipoxygenase–mediated enzymatic lipid oxidation regulates DC maturation and function T Rothe, F Gruber, S Uderhardt, N Ipseiz, S Rössner, O Oskolkova, ... The Journal of clinical investigation 125 (5), 1944-1954, 2015 | 105 | 2015 |
| The nuclear receptor Nr4a1 mediates anti-inflammatory effects of apoptotic cells N Ipseiz, S Uderhardt, C Scholtysek, M Steffen, G Schabbauer, A Bozec, ... The Journal of Immunology 192 (10), 4852-4858, 2014 | 96 | 2014 |
| Tissue‐resident macrophages actively suppress IL‐1beta release via a reactive prostanoid/IL‐10 pathway N Ipseiz, RJ Pickering, M Rosas, VJ Tyrrell, LC Davies, SJ Orr, ... The EMBO journal 39 (14), e103454, 2020 | 63 | 2020 |
| Moonlighting osteoclasts as undertakers of apoptotic cells U Harre, H Keppeler, N Ipseiz, A Derer, K Poller, M Aigner, G Schett, ... Autoimmunity 45 (8), 612-619, 2012 | 61 | 2012 |
| Macrophage reprogramming for therapy VMT Bart, RJ Pickering, PR Taylor, N Ipseiz Immunology 163 (2), 128-144, 2021 | 57 | 2021 |
| PPARβ/δ directs the therapeutic potential of mesenchymal stem cells in arthritis P Luz-Crawford, N Ipseiz, G Espinosa-Carrasco, A Caicedo, G Tejedor, ... Annals of the rheumatic diseases 75 (12), 2166-2174, 2016 | 52 | 2016 |
| The nuclear receptor Nr4a1 acts as a microglia rheostat and serves as a therapeutic target in autoimmune-driven central nervous system inflammation T Rothe, N Ipseiz, M Faas, S Lang, F Perez-Branguli, D Metzger, ... The Journal of Immunology 198 (10), 3878-3885, 2017 | 43 | 2017 |
| No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis D Kienhöfer, J Hahn, I Schubert, C Reinwald, N Ipseiz, SC Lang, ... PloS one 9 (12), e115474, 2014 | 41 | 2014 |
| Eosinophils are not essential for maintenance of murine plasma cells in the bone marrow K Haberland, JA Ackermann, N Ipseiz, S Culemann, K Pracht, ... European Journal of Immunology 48 (5), 822-828, 2018 | 40 | 2018 |
| The role of macrophages during zebrafish injury and tissue regeneration under infectious and non-infectious conditions C Bohaud, MD Johansen, C Jorgensen, N Ipseiz, L Kremer, F Djouad Frontiers in Immunology 12, 707824, 2021 | 24 | 2021 |
| NR4A1 regulates motility of osteoclast precursors and serves as target for the modulation of systemic bone turnover C Scholtysek, N Ipseiz, C Böhm, B Krishnacoumar, M Stenzel, ... Journal of Bone and Mineral Research 33 (11), 2035-2047, 2018 | 22 | 2018 |
| PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone mass DIH Müller, C Stoll, K Palumbo-Zerr, C Böhm, B Krishnacoumar, N Ipseiz, ... Scientific reports 10 (1), 8428, 2020 | 20 | 2020 |
| Gilz-Activin A as a novel signaling axis orchestrating mesenchymal stem cell and Th17 cell interplay P Luz-Crawford, G Espinosa-Carrasco, N Ipseiz, R Contreras, G Tejedor, ... Theranostics 8 (3), 846, 2018 | 18* | 2018 |
| The role of macrophages during mammalian tissue remodeling and regeneration under infectious and non-infectious conditions C Bohaud, MD Johansen, C Jorgensen, L Kremer, N Ipseiz, F Djouad Frontiers in Immunology 12, 707856, 2021 | 14 | 2021 |
| Effective in vivo gene modification in mouse tissue-resident peritoneal macrophages by intraperitoneal delivery of lentiviral vectors N Ipseiz, MA Czubala, VMT Bart, LC Davies, RH Jenkins, P Brennan, ... Molecular Therapy Methods & Clinical Development 16, 21-31, 2020 | 14 | 2020 |
